Aura Biosciences, Inc. (AURA)
7.185
-0.18
(-2.38%)
USD |
NASDAQ |
Sep 09, 16:00
7.185
0.00 (0.00%)
After-Hours: 16:48
Aura Biosciences Total Assets (Quarterly) : 348.13M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 348.13M |
| March 31, 2026 | 137.68M |
| December 31, 2025 | 319.98M |
| September 30, 2025 | 190.02M |
| June 30, 2025 | 204.40M |
| March 31, 2025 | 155.40M |
| December 31, 2024 | 182.50M |
| September 30, 2024 | 205.34M |
| June 30, 2024 | 218.28M |
| March 31, 2024 | 235.02M |
| December 31, 2023 | 255.08M |
| September 30, 2023 | 179.77M |
| Date | Value |
|---|---|
| June 30, 2023 | 192.74M |
| March 31, 2023 | 206.02M |
| December 31, 2022 | 223.94M |
| September 30, 2022 | 143.15M |
| June 30, 2022 | 135.02M |
| March 31, 2022 | 146.42M |
| December 31, 2021 | 160.03M |
| September 30, 2021 | 90.70M |
| June 30, 2021 | 98.65M |
| March 31, 2021 | 105.10M |
| December 31, 2020 | 22.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.86M |
| Shareholders Equity (Quarterly) | 315.27M |
| Debt to Equity Ratio | 0.0526 |
| Current Ratio | 16.82 |
| Net Debt Paydown Yield | 0.05% |